FMED: FIDELITY DISRUPTIVE MEDICINE ETF
ETF Education Report: Fidelity Disruptive Medicine ETF (FMED)
What this ETF is trying to do
The Fidelity Disruptive Medicine ETF (ticker: FMED) is an exchange-traded fund that focuses on the medical field. It holds a variety of companies involved in medicine and biotechnology. This report uses data as of August 11, 2026.
What the numbers show
The current price of one share is $30.22. Looking back at history, we can see how the share price has moved:
• One-Year Performance: The one-year price return was approximately 31.06%. This measures only the change in the share price. The one-year total return was also approximately 31.06%, which includes distributions (though none were paid).
• Year-to-Date (YTD): So far this year, the YTD price return is approximately 11.71%. The YTD total return is also approximately 11.71%.
• Three-Year Performance: Over the last three years, the three-year price return was approximately 26.18%. The three-year total return was approximately 26.75%.
To understand the growth, we can look at an estimated price from roughly one year ago, which was $23.06. For example, if you had invested $10,000 in this ETF one year ago based on these estimated prices, your investment would have grown to approximately $13,105 based on the share-price change alone.
Income and distribution explanation
Some ETFs pay out cash to investors regularly; this is called a distribution. For FMED, no distributions were detected over the last 12 months, and the distribution yield is 0%. This means the fund did not provide cash income to shareholders during this period.
NAV erosion explanation
"NAV erosion" refers to a situation where the value of the underlying assets in the fund decreases significantly. When an ETF's share price falls, it is called a share-price decline. While a falling price can sometimes be linked to NAV erosion, they are not the same thing.
For FMED, the erosion-risk score is 100, and the label indicates "No price erosion detected." There is no severe erosion-risk flag for this ETF.
Top Holdings
The following is a partial list of the top holdings in this ETF. Please note that holdings can change over time.
• Danaher Corp (DHR): 3.80%
• Thermo Fisher Scientific Inc (TMO): 3.60%
• Alnylam Pharmaceuticals Inc (ALNY): 2.93%
• Argenx SE ADR (ARGX): 2.90%
• Cogent Biosciences Inc (COGT): 2.81%
• Revolution Medicines Inc (RVMD): 2.79%
• Illumina Inc (ILMN): 2.48%
• Intuitive Surgical Inc (ISRG): 2.47%
• Kymera Therapeutics Inc (KYMR): 2.40%
• Moderna Inc (MRNA): 2.24%
Pros
• The ETF has shown positive price returns over the one-year, year-to-date, and three-year periods.
• The erosion-risk measurements suggest a "good" status with no detected price erosion.
Cons
• This ETF does not currently provide cash distributions or income.
Beginner takeaway
FMED is an ETF that has experienced share-price growth over the last year and three years. It focuses on medical companies rather than paying out regular cash income to investors. Always remember that past performance does not guarantee what will happen in the future.
Top Holdings
Structured portfolio holdings supplied by the ETF data provider. These figures are not generated by the AI article.
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | n/a | TXG | 5.19% |
| 2 | n/a | n/a | 4.42% |
| 3 | THERMO FISHER SCIENTIFIC INC | TMO | 3.83% |
| 4 | DANAHER CORP | DHR | 3.73% |
| 5 | NATERA INC | NTRA | 3.50% |
| 6 | ARGENX SE ADR | ARGX | 3.20% |
| 7 | n/a | LFST | 3.00% |
| 8 | REVOLUTION MEDICINES INC ORDINARY SHARES | RVMD | 2.87% |
| 9 | ILLUMINA INC | ILMN | 2.82% |
| 10 | HEARTFLOW INC | HTFL | 2.59% |